Forum

Watch for the case to be appealed to the Supreme Court. For the immediate: Innocent human lives will be saved. The pervasive mailing of the abortion drug is the dark and macabre “growth sector” of the abortion industry. Post Millennial: A federal appeals court on Friday blocked a 2023 Food and Drug Administration (FDA) policy that allowed the abortion pill mifepristone to be prescribed through telemedicine and delivered by mail. A three-judge panel on the 5th Circuit Court of Appeals unanimously ruled in favor of a Louisiana challenge to the Biden-era policy, finding that it violated the state’s sovereignty. “The regulation creates an effective way for an out-of-state prescriber to place the drug in the hands of Louisianans in defiance of Louisiana law,” the judges wrote. They found that the policy undermined state laws aimed at “protecting unborn human life” and has caused “irreparable harm.” The court’s decision applies nationwide and restores the previous FDA policy, which requires the pill to be distributed only through in-person clinics (Post Millenial). Washington Times: Mifepristone was approved in 2000, and surveys have found that the majority of U.S. abortions now use pills. The in-person dispensing requirement was eliminated in 2023 when the Biden administration finalized rules ending it, and Louisiana’s lawsuit targeted those specific regulatory changes (Washington Times).